​
​

Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Rigel Pharmaceuticals Ownership Summary

Rigel Pharmaceuticals is owned by 0.01% institutional investors, 2.18% insiders, and 97.81% retail investors. Barclays is the largest institutional shareholder, holding 0.01% of RIGL shares. Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund, with 5.97% of its assets in Rigel Pharmaceuticals shares.

RIGL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRigel Pharmaceuticals0.01%2.18%97.81%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Barclays10.57K0.01%$88.00K
Ifp advisors1.00K0.00%$807.00
Voya investment management---
National bank of canada /fi/---
Prudential financial---
Legal & general group---
Jacobs levy equity management---
Loring wolcott & coolidge fiduciary advisors llp/ma---
Hexagon capital partners2.00-$17.00
Proshare advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Voya investment management---
Proshare advisors---
National bank of canada /fi/---
Prudential financial---
Legal & general group---
Loring wolcott & coolidge fiduciary advisors llp/ma---
Jacobs levy equity management---
Hexagon capital partners2.00-$17.00
Price t rowe associates inc /md/---

Top Buyers

HolderShares% AssetsChange
Eversource wealth advisors63.00-63.00
Ifp advisors1.00K--
Hexagon capital partners2.00--20.00
Loring wolcott & coolidge fiduciary advisors llp/ma---27.00
Institutional & family asset management10.00--90.00

Top Sellers

HolderShares% AssetsChange
Armistice capital---15.36M
Blackrock---14.80M
Morgan stanley---14.44M
Vanguard group---9.37M
Soleus capital management---9.24M

New Positions

HolderShares% AssetsChangeValue
Eversource wealth advisors63.00-63.00$667.00

Sold Out

HolderChange
Loring wolcott & coolidge fiduciary advisors llp/ma-27.00
Nelson, van denburg & campbell wealth management group-126.00
Nisa investment advisors-432.00
Mather group, llc.-450.00
Ronald blue trust-500.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20249-92.62%12,725-99.99%-0.00%2-96.00%5-87.18%
Mar 31, 20241223.39%111,001,2854.17%631.69%50-9.09%3930.00%
Dec 31, 20231185.36%106,553,9720.27%611.65%5530.95%30-14.29%
Sep 30, 2023112-7.44%106,263,944-3.96%601.50%4210.53%35-25.53%
Jun 30, 2023121-6.20%110,640,823-1.72%631.51%38-29.63%4727.03%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Invesco Dorsey Wright SmallCap Momt ETF1.05M5.97%-
Vanguard Total Stock Mkt Idx Inv548.78K3.12%-
iShares Russell 2000 ETF462.77K2.63%-1.04K
Vanguard Institutional Extnd Mkt Idx Tr242.74K1.38%-
Fidelity Small Cap Index177.30K1.01%-4.18K
Delaware Healthcare I160.00K0.91%-
iShares Russell 2000 Growth ETF124.05K0.70%-
State St Russell Sm/Mid Cp® Indx NL Cl C107.17K0.61%-3.60K
Fidelity Extended Market Index102.50K0.58%-414.00
Voya Small Company Port I95.66K0.54%-2.41K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 05, 2024Santos David A EVP, Chief Commercial OfficerSell$10.17K
Feb 02, 2024Santos David A EVP, Chief Commercial OfficerSell$6.33K
Feb 02, 2024Schorno Dean L EVP & Chief Financial OfficerSell$6.33K
Feb 05, 2024Schorno Dean L EVP & Chief Financial OfficerSell$8.01K
Feb 02, 2024RODRIGUEZ RAUL R CEO, PresidentSell$25.26K

Insider Transactions Trends

DateBuySell
2024 Q1-6
2023 Q2--
2023 Q1-4
2022 Q4--
2022 Q3--

RIGL Ownership FAQ

Who Owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals shareholders are primarily institutional investors at 0.01%, followed by 2.18% insiders and 97.81% retail investors. The average institutional ownership in Rigel Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Rigel Pharmaceuticals falls below.

Who owns the most shares of Rigel Pharmaceuticals?

Rigel Pharmaceuticals’s largest shareholders are Barclays (10.57K shares, 0.01%), Ifp advisors (1K shares, 0.00%), and Voya investment management (0 shares, 0%). Together, they hold 0.01% of Rigel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rigel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Rigel Pharmaceuticals.

Who is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Rigel Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Rigel Pharmaceuticals shares?

Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund holder of Rigel Pharmaceuticals shares, with 5.97% of its total shares outstanding invested in 1.05M Rigel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools